Veryan gets £2.5 million
West Sussex-based biotech concern Veryan Med, which specialises in addressing vascular disease, has received £2.5 million in a further funding round from Imperial Innovations.
News
West Sussex-based biotech concern Veryan Med, which specialises in addressing vascular disease, has received £2.5 million in a further funding round from Imperial Innovations.
News
News
Partner content
Accounting and Finance Software
Accounting and Finance Software